According to ClinicalTrials.gov, as of 5 th December 2022, no phase III clinical trial on the use of GSH in NAFLD is currently ongoing or recruiting
15,16 Studies continue to show that patients who adhere to these recommendations have significantly lower nutrient deficiency rates than those who take supplements, but not at the recommended prevention levels for a post-MBS patient, or patients who take no supplements at all
Studies have shown that it can promote healing by improving blood flow and reducing inflammation, particularly in sports-related injuries such as muscle or tendon tears
Pharmacokinetic studies demonstrated approximately 38% oral bioavailability and blood-brain barrier penetration, unusual for a peptide-based compound and attributable to Dihexa's small size (504.66 Da) and hydrophobic modifications
However, some find absorption issues persist due to digestive factors or medication use